With Amulet or Watchman, 50% of patients still leak either way

Left atrial appendage (LAA) occlusion procedures are designed to reduce the risk of thromboembolism in patients who have non-valvular atrial fibrillation, but a study presented at the 2023 Transcatheter Cardiovascular Therapeutics annual meeting in San Francisco demonstrated that about half of patients continue to have LAA leaks – and potentially the risk of dangerous blood clots and stroke – a year after the procedure.

Related Keywords

San Francisco , California , United States , , Cardiovascular Therapeutics , Conference , Boston Scientific Corp , Abbott Laboratories Inc , Amplatzer Amulet , Watchman , Left Atrial Appendage , Occlusion Devices , Transcatheter Cardiovascular Therapeutics ,